RMD

ResMed
D

RMD

253.500
USD
-2.36
(-0.92%)
مغلق
حجم التداول
16,318
الربح لكل سهم
9
العائد الربحي
0.83
P/E
28
حجم السوق
37,170,045,647
أصول ذات صلة
ALC
ALC
-1.460
(-1.64%)
87.820 USD
ALGN
ALGN
-0.170
(-0.09%)
196.850 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
PHG
PHG
-0.345
(-1.41%)
24.175 USD
PHM
PHM
-2.870
(-2.58%)
108.470 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
المزيد
الأخبار المقالات

العنوان: ResMed

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.